Giant Cell Glioblastoma
NCI Definition: A rare histological variant of glioblastoma (WHO grade IV) with a predominance of bizarre, multinucleated giant cells, an occasionally abundant stromal reticulin network, and a high frequency of TP53 mutations. (WHO) 
There is 1 clinical trial for giant cell glioblastoma, of which 1 is open and 0 are completed or closed. Of the trial that contains giant cell glioblastoma as an inclusion criterion, 1 is phase 1 (1 open).
G207 is the most common intervention in giant cell glioblastoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.